Russell Investments Group, Ltd. - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 165 filers reported holding NEVRO CORP in Q2 2019. The put-call ratio across all filers is 5.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of NEVRO CORP
ValueSharesWeighting
Q2 2023$193,929
-85.7%
7,629
-79.6%
0.00%
-100.0%
Q1 2023$1,352,549
-33.0%
37,415
-26.6%
0.00%
-25.0%
Q4 2022$2,018,728
+19.5%
50,978
+40.6%
0.00%0.0%
Q3 2022$1,689,000
-10.3%
36,252
-15.7%
0.00%0.0%
Q2 2022$1,883,000
+22.3%
42,984
+101.7%
0.00%
+33.3%
Q1 2022$1,540,000
-51.8%
21,307
-45.9%
0.00%
-40.0%
Q4 2021$3,192,000
+147.6%
39,400
+255.1%
0.01%
+150.0%
Q3 2021$1,289,000
-48.8%
11,094
-27.0%
0.00%
-50.0%
Q2 2021$2,518,000
+238.4%
15,194
+184.5%
0.00%
+300.0%
Q1 2021$744,000
-89.3%
5,340
-86.7%
0.00%
-92.9%
Q4 2020$6,974,000
+12.8%
40,293
-9.2%
0.01%
+7.7%
Q3 2020$6,181,000
+20.5%
44,385
+3.3%
0.01%
+18.2%
Q2 2020$5,131,000
+20.2%
42,959
+0.6%
0.01%0.0%
Q1 2020$4,269,000
-42.4%
42,705
-32.2%
0.01%
-21.4%
Q4 2019$7,408,000
-5.8%
63,032
-31.1%
0.01%
-6.7%
Q3 2019$7,868,000
+32.6%
91,5190.0%0.02%
+36.4%
Q2 2019$5,933,000
+16380.6%
91,519
+9698.6%
0.01%
Q4 2018$36,000
-95.9%
934
-94.0%
0.00%
-100.0%
Q3 2018$887,000
-39.2%
15,563
-14.9%
0.00%
-33.3%
Q2 2018$1,460,000
-71.7%
18,298
-69.2%
0.00%
-66.7%
Q1 2018$5,157,000
+496.9%
59,503
+386.5%
0.01%
+800.0%
Q4 2017$864,000
-1.1%
12,232
+27.2%
0.00%0.0%
Q3 2017$874,000
+17.5%
9,619
-3.8%
0.00%0.0%
Q2 2017$744,000
-89.2%
10,004
-86.4%
0.00%
-92.3%
Q1 2017$6,875,000
+39.7%
73,402
+8.5%
0.01%
+30.0%
Q4 2016$4,922,00067,6350.01%
Other shareholders
NEVRO CORP shareholders Q2 2019
NameSharesValueWeighting ↓
BRAIDWELL LP 1,776,368$34,141,7931.08%
ARMISTICE CAPITAL, LLC 3,456,000$66,424,3201.02%
Palo Alto Investors LP 386,832$7,434,9110.70%
Rock Springs Capital Management LP 1,211,600$23,286,9520.62%
ArrowMark Colorado Holdings LLC 2,468,110$47,437,0740.58%
TD Capital Management LLC 84,648$1,626,9350.20%
Venator Management LLC 25,000$480,5000.18%
DAFNA Capital Management LLC 28,000$538,1600.17%
FRED ALGER MANAGEMENT, LLC 1,053,812$20,254,2660.12%
Counterpoint Mutual Funds LLC 6,844$131,5420.11%
View complete list of NEVRO CORP shareholders